Skip to main content
NUVL logo

Nuvalent, Inc.

NUVLNASDAQHealthcareBiotechnology

$123.96Today:- (-)1Y +37.09%

As of Jul 21, 2026 close

Market cap
$9.75B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$85.00$123.99
Volume (live)
-
Avg. volume (3M)
-

Nuvalent (NUVL) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Nuvalent used $275.21M of cash in operating activities. Free cash flow was −$275.21M.

Nuvalent Cash Flow Statement Analysis

Values in billions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Nuvalent, Inc. (NUVL) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-0.43-0.26-0.13-0.08-0.05-0.01-0.01
Depreciation & Amortization0.000.000.000.000.000.000.00
Deferred Income Tax0.000.000.00-0.010.000.000.00
Stock Based Compensation0.090.060.030.010.000.000.00
Change in Working Capital0.020.010.010.010.000.000.00
Change in Accounts Payable0.020.000.000.000.000.000.00
Change in Other Working Capital0.040.020.010.000.000.000.00
Other Operating Activities0.040.00-0.010.010.000.000.00
Net Cash from Operating Activities-0.28-0.19-0.10-0.06-0.04-0.01-0.01
Investing Activities
Purchases of Investments-1.06-1.02-0.46-0.21-0.220.000.00
Sales/Maturities of Investments0.930.450.320.200.000.000.00
Net Cash from Investing Activities-0.12-0.57-0.14-0.01-0.220.000.00
Financing Activities
Debt Repayment0.000.000.000.000.000.000.00
Common Stock Issued0.520.570.320.250.180.000.00
Other Financing Activities0.000.000.010.000.140.020.00
Net Cash from Financing Activities0.520.570.340.250.320.020.00
Summary
Net Change in Cash0.12-0.190.090.170.060.01-0.01
Cash at Beginning of Period0.150.340.240.070.010.000.01
Cash at End of Period0.260.150.340.240.070.010.00
Free Cash Flow-0.28-0.19-0.10-0.06-0.04-0.01-0.01

Source: Company financial statements from annual and quarterly filings. Data as of Mar 31, 2026. Data sources and methodology

Frequently Asked Questions About Nuvalent Cash Flow

What is Nuvalent's free cash flow?

Nuvalent had negative free cash flow of $275.21M in fiscal 2025 (fiscal year ended Dec 31, 2025).

Does Nuvalent pay dividends or buy back shares?

Nuvalent's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition